Novel technologies for the prevention and treatment of dental caries: A patent survey

Expert Opinion on Therapeutic Patents

Volumn 20, Issue 5, 2010, Pages 681-694

  Chen, Fu ^a   Wang, Dong ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antimicrobial; Dental caries; Drug delivery; Fluoride therapy; Sugar substitute

Indexed keywords

CASEIN; CETYLPYRIDINIUM SALT; CHLORHEXIDINE; FLUORIDE; PENICILLIN DERIVATIVE; PEPTIDE VACCINE; PLANT EXTRACT; POLYPEPTIDE ANTIBIOTIC AGENT; PROBIOTIC AGENT; SANGUINARIA EXTRACT; SORBITOL; SUGAR; TRICLOSAN; UNCLASSIFIED DRUG; VANCOMYCIN; XYLITOL;

BIOFILM; CHEMOPROPHYLAXIS; CHILDHOOD DISEASE; DEMINERALIZATION; DENTAL CARIES; HEALTH SURVEY; HUMAN; LIFESPAN; MASSAGE; NONHUMAN; PATENT; REVIEW; SANGUINARIA; SUBSTITUTION THERAPY; TECHNOLOGY; TOOTH;

ADOLESCENT; ADULT; ANIMALS; DENTAL CARIES; DENTAL PLAQUE; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; PATENTS AS TOPIC; TOOTH DEMINERALIZATION; TOOTH REMINERALIZATION; YOUNG ADULT;

EID: 77951595160     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543771003720491     Document Type: Review

References (174)

1. Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet 2007;369(9555):51-59
2. Featherstone JD. The science and practice of caries prevention. J Am Dent Assoc 2000;131(7):887-899
3. Featherstone JD. Prevention and reversal of dental caries: role of low level fluoride. Community Dent Oral Epidemiol 1999;27(1):31-40
4. Garcia-Godoy F, Hicks MJ. Maintaining the integrity of the enamel surface: the role of dental biofilm, saliva and preventive agents in enamel demineralization and remineralization. J Am Dent Assoc 2008;139(Suppl):25S-34S
5. Fejerskov O, Kidd E, editors. Dental caries: the disease and its clinical management. Blackwell Monksgaard, Copenhagen, Denmark; 2003
6. Marsh P, Martin MV. Oral microbiology. 4th edition. Wright, Oxford; 1999
7. Kidd EA, Fejerskov O. What constitutes dental caries? Histopathology of carious enamel and dentin related to the action of cariogenic biofilms. J Dent Res 2004;83(Spec No C):C35-8 (Pubitemid 44126040)
8. Featherstone JD. The continuum of dental caries--evidence for a dynamic disease process. J Dent Res 2004;83 Spec No C:C39-42
9. Featherstone JD. Dental caries: a dynamic disease process. Aust Dent J 2008;53(3):286-291
10. Seow WK. Biological mechanisms of early childhood caries. Community Dent Oral Epidemiol 1998;26(1 Suppl):8-27 (Pubitemid 128543832)
11. ten Cate JM, Featherstone JD. Mechanistic aspects of the interactions between fluoride and dental enamel. Crit Rev Oral Biol Med 1991;2(3):283-296
12. Marsh PD, Bradshaw DJ. Dental plaque as a biofilm. J Ind Microbiol 1995;15(3):169-175
13. Scheie AA, Petersen FC. The biofilm concept: consequences for future prophylaxis of oral diseases? Crit Rev Oral Biol Med 2004;15(1):4-12
14. Zander HA, Bibby BG. Penicillin and caries activity. J Dent Res 1947;26(5):365-368
15. Jordan HV, De Paola PF. Effect of a topically applied 3 percent vancomycin gel on Streptococcus mutans on different tooth surfaces. J Dent Res 1974;53(1):115-120
16. Anderson MH. A review of the efficacy of chlorhexidine on dental caries and the caries infection. J Calif Dent Assoc 2003;31(3):211-214
17. Duckworth RM. The science behind caries prevention. Int Dent J 1993;43(6 Suppl 1):529-539
18. Walker C. Effects of sanguinarine and Sanguinaria extract on the microbiota associated with the oral cavity. J Can Dent Assoc 1990;56(7 Suppl):13-30
19. Emilson CG. Potential efficacy of chlorhexidine against mutans streptococci and human dental caries. J Dent Res 1994;73(3):682-691
20. Marshand PD, Bradshaw DJ. Microbiological effects of new agents in dentifrices for plaque control. Int Dent J 1993;43:399-406
21. Balakrishnan M, Simmonds RS, Tagg JR. Dental caries is a preventable infectious disease. Aust Dent J 2000;45(4):235-245
22. Guggenheim B, Giertsen E, Schupbach P, Shapiro S. Validation of an in vitro biofilm model of supragingival plaque. J Dent Res 2001;80(1):363-370 (Pubitemid 32501339)
23. Shapiro S, Giertsen E, Guggenheim B. An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses. Caries Res 2002;36(2):93-100
24. Moshrefi A. Chlorhexidine. J West Soc Periodontol Periodontal Abstr 2002;50(1):5-9
25. Yates R, Jenkins S, Newcombe R, et al. A 6-month home usage trial of a 1% chlorhexidine toothpaste (1). Effects on plaque, gingivitis, calculus and toothstaining. J Clin Periodontol 1993;20(2):130-138 (Pubitemid 23051682)
26. Barton S, Galley E. Oral hygiene composition. US5695745; 1997
27. Furia TE, Schenkel AG. A new, broad spectrum bacteriostat. Soap Chem Specialties 1968;44:47--50,116--22
28. Stephen KW, Saxton CA, Jones CL, et al. Control of gingivitis and calculus by a dentifrice containing a zinc salt and triclosan. J Periodontol 1990;61(11):674-679
29. Svatun B, Sadxton CA, Huntington E, Cummins D. The effects of three silica dentifrices containing Triclosan on supragingival plaque and calculus formation and on gingivitis. Int Dent J 1993;43(4 Suppl 1):441-452
30. Raghavan SL, Schuessel K, Davis A, Hadgraft J. Formation and stabilisation of triclosan colloidal suspensions using supersaturated systems. Int J Pharm 2003;261(1-2):153-158 (Pubitemid 36962753)
31. Gilbert RJ, Williams PE. The oral retention and antiplaque efficacy of triclosan in human volunteers. Br J Clin Pharmacol 1987;23(5):579-583
32. Barabolak RM, Witkewitz DL. Anti-plaque emulsions and products containing same. US7022314; 2006
33. Nelson DGA, Sheehan CJ. Cyclodextrins in dental products. US6942848; 2005
34. Gaffar A, Nabi N, Afflitto J. Process for inhibiting S. mutans and caries. US6136298; 2000
35. Iyer LM, Barkans DE, Hench BD. Gums containing antimicrobial agents. US6248309; 2001
36. Nabi N, Mukerjee C, Schmid R, Gaffar A. In vitro and in vivo studies on triclosan/PVM/MA copolymer/NaF combination as an anti-plaque agent. Am J Dent 1989;2 Spec No:197-206
37. Nabi N, Gaffar A. Antibacterial antiplaque oral composition. US4894220; 1990
38. Gaffar A, Afflitto J, Nabi N. Chemical agents for the control of plaque and plaque microflora: an overview. Eur J Oral Sci 1997;105(5 Pt 2):502-507 (Pubitemid 127760448)
39. Gaffar A, Nabi N, Kashuba B, et al. Antiplaque effects of dentifrices containing triclosan/copolymer/NaF system versus triclosan dentifrices without the copolymer. Am J Dent 1990;3 Spec No:S7-14
40. Gaffar A, Afflitto J, Nabi N, et al. Recent advances in plaque, gingivitis, tartar and caries prevention technology. Int Dent J 1994;44(1 Suppl 1):63-70
41. Plochocka K. Polymeric delivery and release systems for oral care actives. US6464961; 2002
42. Chen F, Liu XM, Rice KC, et al. Tooth-binding micelles for dental caries prevention. Antimicrob Agents Chemother 2009;53(11):4898-4902
43. Allaker RP, Douglas CW. Novel anti-microbial therapies for dental plaque-related diseases. Int J Antimicrob Agents 2009;33(1):8-13
44. Darout IA, Albandar JM, Skaug N, Ali RW. Salivary microbiota levels in relation to periodontal status, experience of caries and miswak use in Sudanese adults. J Clin Periodontol 2002;29(5):411-420 (Pubitemid 41697827)
45. Takarada K, Kimizuka R, Takahashi N, et al. A comparison of the antibacterial efficacies of essential oils against oral pathogens. Oral Microbiol Immunol 2004;19(1):61-64 (Pubitemid 38101506)
46. Hamilton-Miller JM. Anti-cariogenic properties of tea (Camellia sinensis). J Med Microbiol 2001;50(4):299-302 (Pubitemid 32239014)
47. Hirasawa M, Takada K, Otake S. Inhibition of acid production in dental plaque bacteria by green tea catechins. Caries Res 2006;40(3):265-270 (Pubitemid 43760303)
48. Fine DH, Furgang D, Lieb R, et al. Effects of sublethal exposure to an antiseptic mouthrinse on representative plaque bacteria. J Clin Periodontol 1996;23(5):444-451
49. Petti S, Scully C. Polyphenols, oral health and disease: a review. J Dent 2009;37(6):413-423
50. Al-Hebshi NN, Nielsen O, Skaug N. In vitro effects of crude khat extracts on the growth, colonization, and glucosyltransferases of Streptococcus mutans. Acta Odontol Scand 2005;63(3):136-142 (Pubitemid 40868472)
51. Rahim ZH, Khan HB. Comparative studies on the effect of crude aqueous (CA) and solvent (CM) extracts of clove on the cariogenic properties of Streptococcus mutans. J Oral Sci 2006;48(3):117-123
52. Koo H, Nino de Guzman P, Schobel BD, et al. Influence of cranberry juice on glucan-mediated processes involved in Streptococcus mutans biofilm development. Caries Res 2006;40(1):20-27 (Pubitemid 41797901)
53. Yu HH, Lee DH, Seo SJ, You YO. Anticariogenic properties of the extract of Cyperus rotundus. Am J Chin Med 2007;35:497-505
54. Brighenti FL, Luppens SB, Delbem AC, et al. Effect of Psidium cattleianum leaf extract on Streptococcus mutans viability, protein expression and acid production. Caries Res 2008;42(2):148-154
55. Yu HH, Lee JS, Lee KH, et al. Saussurea lappa inhibits the growth, acid production, adhesion, and water-insoluble glucan synthesis of Streptococcus mutans. J Ethnopharmacol 2007;111:413-417
56. Papetti A, Pruzzo C, Daglia M, et al. Effect of barley coffee on the adhesive properties of oral streptococci. J Agric Food Chem 2007;55(2):278-284 (Pubitemid 46586307)
57. Yamamoto H, Ogawa T. Antimicrobial activity of perilla seed polyphenols against oral pathogenic bacteria. Biosci Biotechnol Biochem 2002;66(4):921-924 (Pubitemid 39251367)
58. Mezine I, Zhang HZ, Petteruti M, et al. Oral care compositions derived from the Labiatae family. US7517541; 2009
59. Ofek I, Weiss E, Kashman Y, et al. Anti-microbial-adhesion fraction derived from vaccinium. US6843993; 2005
60. Majeed M, Prakash S. Composition and methods containing an antimicrobial essential oil extended from Coleus forskohlii. US6607712; 2003
61. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994;264(5157):375-382 (Pubitemid 24178900)
62. Schutze GE, Kaplan SL, Jacobs RF. Resistant Pneumococcus: a worldwide problem. Infection 1994;22(4):233-237
63. Pazgier M, Hoover DM, Yang D, et al. Human beta-defensins. Cell Mol Life Sci 2006;63(11):1294-1313
64. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005;3(3):238-250
65. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415(6870):389-395 (Pubitemid 34100944)
66. Marr AK, Gooderham WJ, Hancock RE. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 2006;6(5):468-472
67. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25- dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004;173(5):2909-2912 (Pubitemid 39141992)
68. Rennie J, Arnt L, Tang H, et al. Simple oligomers as antimicrobial peptide mimics. J Ind Microbiol Biotechnol 2005;32(7):296-300 (Pubitemid 40980310)
69. Beckloff N, Laube D, Castro T, et al. Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother 2007;51(11):4125-4132 (Pubitemid 350057814)
70. Reynolds EC, Dashper SG, O'Brien-Simpson NM, et al. Antimicrobial peptides. US7588752; 2009
71. Leung KP, Concannon SP. Antimicrobial peptide and methods of use thereof. US749498; 2009
72. Bobek LA. D-isomers of antimicrobial peptide. US7271239; 2007
73. Eckert R, He J, Yarbrough DK, et al. Targeted killing of Streptococcus mutans by a pheromone-guided 'smart' antimicrobial peptide. Antimicrob Agents Chemother 2006;50(11):3651-3657 (Pubitemid 44684877)
74. Li L, He J, Eckert R, et al. Design and characterization of an acid-activated antimicrobial peptide. Chem Biol Drug Des 2009;75:127-132
75. Islam B, Khan SN, Khan AU. Dental caries: from infection to prevention. Med Sci Monit 2007;13(11):RA196-203 (Pubitemid 350106405)
76. Youngman KR, Lazarus NH, Butcher EC. Mucosal immunology. 3rd edition. Elsevier, Burlington; 2005
77. Taubman MA, Nash DA. The scientific and public-health imperative for a vaccine against dental caries. Nat Rev Immunol 2006;6(7):555-563
78. Russell MW, Hajishengallis G, Childers NK, Michalek SM. Secretory immunity in defense against cariogenic mutans streptococci. Caries Res 1999;33(1):4-15
79. Shivakumar KM, Vidya SK, Chandu GN. Dental caries vaccine. Indian J Dent Res 2009;20(1):99-106
80. Hajishengallis G, Nikolova E, Russell MW. Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage. Infect Immun 1992;60(12):5057-5064
81. Takahashi I, Okahashi N, Matsushita K, et al. Immunogenicity and protective effect against oral colonization by Streptococcus mutans of synthetic peptides of a streptococcal surface protein antigen. J Immunol 1991;146(1):332-336
82. Hajishengallis G, Russell MW, Michalek SM. Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization. Infect Immun 1998;66(4):1740-1743
83. Ma JK, Hunjan M, Smith R, et al. An investigation into the mechanism of protection by local passive immunization with monoclonal antibodies against Streptococcus mutans. Infect Immun 1990;58(10):3407-3414 (Pubitemid 20293454)
84. Lehner T, Kelly C. Polypeptide fragments capable of competition with Streptococcus mutans antigen I/II. US6500433; 2002
85. Finnern R, Fischer R. Diabody which specifically binds Streptococcus surface antigen I/II and methods of use thereof. US7625561; 2009
86. Taubman MA, Holmberg CJ, Smith DJ. Immunization of rats with synthetic peptide constructs from the glucan-binding or catalytic region of mutans streptococcal glucosyltransferase protects against dental caries. Infect Immun 1995;63(8):3088-3093
87. Taubman MA, Holmberg CJ, Smith DJ. Diepitopic construct of functionally and epitopically complementary peptides enhances immunogenicity, reactivity with glucosyltransferase, and protection from dental caries. Infect Immun 2001;69(7):4210-4216
88. Smith DJ, Taubman MA. Glucosyltransferase immunogens. US7056517; 2006
89. Smith DJ, Taubman MA. Synthetic peptide vaccines for dental caries. US6827936; 2004
90. Smith DJ, Taubman MA. Experimental immunization of rats with a Streptococcus mutans 59-kilodalton glucan-binding protein protects against dental caries. Infect Immun 1996;64(8):3069-3073
91. Smith DJ, Taubman MA. Immunogenicity of glucan binding protein. US7323175; 2008
92. Smith DJ, Taubman MA. Glucan binding protein and glucosyltransferase immunogens. US7163682; 2007
93. da Conceicao Tavares Gomes MD, das Neves Ferreira da Silva PM, Rua Vilanova MJ. Vaccine against dental caries based on virulence-associated immunomodulatory extracellular proteins produced by the cariogenic bacteria Streptococcus sobrinus and Streptococcus mutans. US7541041; 2009
94. Lees A, Taubman MA, Smith DJ. Conjugate vaccines for the prevention of dental caries. US7101562; 2006
95. Meurman JH. Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci 2005;113(3):188-196
96. Nase L, Hatakka K, Savilahti E, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 2001;35:412-420 (Pubitemid 33636860)
97. Caglar E, Cildir SK, Ergeneli S, et al. Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol Scand 2006;64(5):314-318 (Pubitemid 44343799)
98. Caglar E, Sandalli N, Twetman S, et al. Effect of yogurt with Bifidobacterium DN-173 010 on salivary mutans streptococci and lactobacilli in young adults. Acta Odontol Scand 2005;63(6):317-320 (Pubitemid 43240796)
99. Mollstam B, Connolly E. Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries. US7517681; 2009
100. He X, Lux R, Kuramitsu HK, et al. Achieving probiotic effects via modulating oral microbial ecology. Adv Dent Res 2009;21(1):53-56
101. Chilcott CN, Tagg JR. Antimicrobial composition. US7226590; 2007
102. Tong H, Chen W, Merritt J, et al. Streptococcus oligofermentans inhibits Streptococcus mutans through conversion of lactic acid into inhibitory H2O2: a possible counteroffensive strategy for interspecies competition. Mol Microbiol 2007;63(3):872-880 (Pubitemid 46105909)
103. Hillman JD. Replacement therapy for dental caries. US5607672; 1997
104. Hillman JD. Lactate dehydrogenase mutants of Streptococcus mutans. US4324860; 1982
105. Hillman JD. Method of controlling dental caries with streptococcus mutans mutant strains. US4133875; 1979
106. Hillman JD, Brooks TA, Michalek SM, et al. Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries. Infect Immun 2000;68(2):543-549
107. Hillman JD. Genetically modified Streptococcus mutans for the prevention of dental caries. Antonie Van Leeuwenhoek 2002;82(1-4):361-366
108. Thurnheer T, van der Ploeg JR, Giertsen E, Guggenheim B. Effects of Streptococcus mutans gtfC deficiency on mixed oral biofilms in vitro. Caries Res 2006;40(2):163-171 (Pubitemid 43325877)
109. Gustafsson BE, Quensel CE, Lanke LS, et al. The Vipeholm dental caries study: the effect of different levels of carbohydrate intake on caries activity in 436 individuals observed for five years. Acta Odontol Scand 1954;11(3-4):232-264
110. Marthaler TM. Epidemiological and clinical dental findings in relation to intake of carbohydrates. Caries Res 1967;1(3):222-238
111. Kandelman D, Gagnon G. A 24-month clinical study of the incidence and progression of dental caries in relation to consumption of chewing gum containing xylitol in school preventive programs. J Dent Res 1990;69(11):1771-1775
112. Konig KG, Schmid P, Schmid R. An apparatus for frequency-controlled feeding of small rodents and its use in dental caries experiments. Arch Oral Biol 1968;13(1):13-26
113. Grafand H, Muhlemann HR. Telemetry of plaque pH from interdental area. Helv Odontol Acta 1996;10:94-101
114. Matsukubo T, Takazoe I. Sucrose substitutes and their role in caries prevention. Int Dent J 2006;56(3):119-130 (Pubitemid 43962564)
115. Edwardsson S, Birkhed D, Mejare B. Acid production from Lycasin, maltitol, sorbitol and xylitol by oral streptococci and lactobacilli. Acta Odontol Scand 1977;35(5):257-263 (Pubitemid 8207991)
116. Waler SM, Rolla G. Effect of xylitol on dental plaque in vivo during carbohydrate challenge. Scand J Dent Res 1983;91(4):256-259
117. Vadeboncoeur C, Trahan L, Mouton C, Mayrand D. Effect of xylitol on the growth and glycolysis of acidogenic oral bacteria. J Dent Res 1983;62(8):882-884 (Pubitemid 13011289)
118. Assev S, Rolla G. Further studies on the growth inhibition of Streptococcus mutans OMZ 176 by xylitol. Acta Pathol Microbiol Immunol Scand B 1986;94(2):97-102 (Pubitemid 16100511)
119. Hausman SZ, Thompson J, London J. Futile xylitol cycle in Lactobacillus casei. J Bacteriol 1984;160(1):211-215 (Pubitemid 14022846)
120. Trahan L, Bareil M, Gauthier L, Vadeboncoeur C. Transport and phosphorylation of xylitol by a fructose phosphotransferase system in Streptococcus mutans. Caries Res 1985;19(1):53-63
121. Ly KA, Milgrom P, Roberts MC, et al. Linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [ISRCTN43479664]. BMC Oral Health 2006;6:6 (Pubitemid 43953232)
122. Milgrom P, Ly KA, Roberts MC, et al. Mutans streptococci dose response to xylitol chewing gum. J Dent Res 2006;85(2):177-181 (Pubitemid 43827752)
123. Soderling E, Isokangas P, Pienihakkinen K, Tenovuo J. Influence of maternal xylitol consumption on acquisition of mutans streptococci by infants. J Dent Res 2000;79(3):882-887 (Pubitemid 32489395)
124. Thorild I, Lindau B, Twetman S. Effect of maternal use of chewing gums containing xylitol, chlorhexidine or fluoride on mutans streptococci colonization in the mothers' infant children. Oral Health Prev Dent 2003;1(1):53-57
125. Isokangas P, Alanen P, Tiekso J, Makinen KK. Xylitol chewing gum in caries prevention: a field study in children. J Am Dent Assoc 1988;117(2):315-320
126. Ly KA, Milgrom P, Rothen M. Xylitol, sweeteners, and dental caries. Pediatr Dent 2006;28(2):154-63; discussion 92-98
127. Ly KA, Milgrom P, Rothen M. The potential of dental-protective chewing gum in oral health interventions. J Am Dent Assoc 2008;139(5):553-563
128. Wennerholm K, Arends J, Birkhed D, et al. Effect of xylitol and sorbitol in chewing-gums on mutans streptococci, plaque pH and mineral loss of enamel. Caries Res 1994;28(1):48-54
129. Kovari H, Pienihakkinen K, Alanen P. Use of xylitol chewing gum in daycare centers: a follow-up study in Savonlinna, Finland. Acta Odontol Scand 2003;61(6):367-370 (Pubitemid 38082339)
130. Twetman S. Consistent evidence to support the use of xylitol- and sorbitol-containing chewing gum to prevent dental caries. Evid Based Dent 2009;10(1):10-11
131. Hayes ML, Roberts KR. The breakdown of glucose, xylitol and other sugar alcohols by human dental plaque bacteria. Arch Oral Biol 1978;23(6):445-451
132. Birkhed D, Edwardsson S, Kalfas S, Svensater G. Cariogenicity of sorbitol. Swed Dent J 1984;8(3):147-154
133. Deshpande A, Jadad AR. The impact of polyol-containing chewing gums on dental caries: a systematic review of original randomized controlled trials and observational studies. J Am Dent Assoc 2008;139(12):1602-1614
134. Lingstrom P, Holm AK, Mejare I, et al. Dietary factors in the prevention of dental caries: a systematic review. Acta Odontol Scand 2003;61(6):331-340 (Pubitemid 38082334)
135. Takatsuka T, Nakao A. US7300645; 2007.
136. Kaufmann K. Hard candy with tooth plaque-neutralizing effect comprising an ammonium salt. US5861169; 1999
137. Featherstone JD. Remineralization, the natural caries repair process--the need for new approaches. Adv Dent Res 2009;21(1):4-7
138. Jenkins GN. Recent changes in dental caries. Br Med J (Clin Res Ed) 1985;291(6505):1297-1298
139. Karulf RE, Coller JA, Bartolo DC, et al. Anorectal physiology testing. A survey of availability and use. Dis Colon Rectum 1991;34(6):464-468
140. Featherstone JD, Zero DT. An in situ model for simultaneous assessment of inhibition of demineralization and enhancement of remineralization. J Dent Res 1992;71 Spec No:804-810
141. Featherstone JD, Glena R, Shariati M, Shields CP. Dependence of in vitro demineralization of apatite and remineralization of dental enamel on fluoride concentration. J Dent Res 1990;69 Spec No:620-5; discussion 34-36 (Pubitemid 20167502)
142. Toumba KJ, Curzon ME. A clinical trial of a slow-releasing fluoride device in children. Caries Res 2005;39(3):195-200 (Pubitemid 40874870)
143. Leverett DH, Featherstone JD, Proskin HM, et al. Caries risk assessment by a cross-sectional discrimination model. J Dent Res 1993;72(2):529-537
144. Eakle WS, Featherstone JD, Weintraub JA, et al. Salivary fluoride levels following application of fluoride varnish or fluoride rinse. Community Dent Oral Epidemiol 2004;32(6):462-469
145. Featherstone JD. Delivery challenges for fluoride, chlorhexidine and xylitol. BMC Oral Health 2006;6(Suppl 1):S8
146. Pessan JP, Al-Ibrahim NS, Buzalaf MA, Toumba KJ. Slow-release fluoride devices: a literature review. J Appl Oral Sci 2008;16(4):238-246
147. Billings RJ, Adair SM, Shields CP, Moss ME. Clinical evaluation of new designs for intraoral fluoride-releasing systems. Pediatr Dent 1998;20(1):17-24
148. Andreadis GA, Toumba KJ, Curzon ME. Slow-release fluoride glass devices: in vivo fluoride release and retention of the devices in children. Eur Arch Paediatr Dent 2006;7(4):258-261
149. Algar B, Toumba J, Curzon M. Method of treating a patient's teeth using fluoride releasing glass composition. US7323160; 2008
150. Jessop N, McLean BS, Lewis P, et al. Dental brackets for retaining a medicament-releasing pellet on a tooth and kits including such brackets. US7097449; 2006
151. Jessop NT, McLean BS, Fischer DE. Fluoride-releasing pellet kit. US6997706; 2006
152. Xu HH, Sun L, Weir MD, et al. Nano DCPA-whisker composites with high strength and Ca and PO(4) release. J Dent Res 2006;85(8):722-727 (Pubitemid 44297327)
153. Xu HH, Weir MD, Sun L, et al. Effects of calcium phosphate nanoparticles on Ca-PO4 composite. J Dent Res 2007;86(4):378-383
154. Xu HH, Moreau JL, Sun L, Chow LC. Strength and fluoride release characteristics of a calcium fluoride based dental nanocomposite. Biomaterials 2008;29(32):4261-4267
155. Xu X, Burgess JO, Ding X, Ling L. Fluoride-releasing compositions. US6703518; 2004
156. Mitra SB. Glass ionomer cement. US6765038; 2004
157. Rutherford B, Somogyi C, White C, Rabins E. Methods for treating dental conditions using tissue scaffolds. US7309232; 2007
158. Faller RV, Baig AA, White DJ. Method of enhancing fluoridation and mineralization of teeth. US7387774; 2008
159. Cozean C, Powell L, Nammour S. Method and laser apparatus for preventing tooth decay. US7163400; 2007
160. Hu D, Zhang YP, DeVizio W, Proskin HM. A clinical investigation of the efficacy of two dentifrices for controlling oral malodor and plaque microflora overnight. J Clin Dent 2008;19:106-110
161. Barnes VM, Richter R, Vandeven M, et al. Clinical investigation of the antiplaque efficacy of a new variant of a commercially available triclosan/ copolymer/fluoride dentifrice. J Clin Dent 2008;19(3):81-84
162. Vered Y, Zini A, Mann J, et al. Comparison of a dentifrice containing 0.243% sodium fluoride, 0.3% triclosan, and 2.0% copolymer in a silica base, and a dentifrice containing 0.243% sodium fluoride in a silica base: a three-year clinical trial of root caries and dental crowns among adults. J Clin Dent 2009;20(2):62-65
163. Matthews DC. Powered toothbrush plus triclosan only as effective as manual brush and fluoride toothpaste for periodontal maintenance patients. Evid Based Dent 2008;9(3):74-75
164. Reynolds EC. Anticariogenic complexes of amorphous calcium phosphate stabilized by casein phosphopeptides: a review. Spec Care Dentist 1998;18(1):8-16
165. Reynolds EC. The prevention of sub-surface demineralization of bovine enamel and change in plaque composition by casein in an intra-oral model. J Dent Res 1987;66(6):1120-1127
166. Reynolds E. Calcium phosphopeptide complexes. US7312193; 2007
167. Bergt C, Fu X, Huq NP, et al. Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. J Biol Chem 2004;279(9):7856-7866 (Pubitemid 38294672)
168. Cross KJ, Huq NL, Reynolds EC. Casein phosphopeptides in oral health-chemistry and clinical applications. Curr Pharm Des 2007;13(8):793-800 (Pubitemid 46585504)
169. Morgan MV, Adams GG, Bailey DL, et al. The anticariogenic effect of sugar-free gum containing CPP-ACP nanocomplexes on approximal caries determined using digital bitewing radiography. Caries Res 2008;42(3):171-184
170. Rao SK, Bhat GS, Aradhya S, et al. Study of the efficacy of toothpaste containing casein phosphopeptide in the prevention of dental caries: a randomized controlled trial in 12- to 15-year-old high caries risk children in bangalore, India. Caries Res 2009;43(6):430-435
171. Andersson A, Skold-Larsson K, Hallgren A, et al. Effect of a dental cream containing amorphous cream phosphate complexes on white spot lesion regression assessed by laser fluorescence. Oral Health Prev Dent 2007;5(3):229-233
172. Bailey DL, Adams GG, Tsao CE, et al. Regression of post-orthodontic lesions by a remineralizing cream. J Dent Res 2009;88(12):1148-1153
173. Yengopal V, Mickenautsch S. Caries preventive effect of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP): a meta-analysis. Acta Odontol Scand 2009;21:1-12
174. Reynolds E. Calcium phosphopeptide complexes. US7312193; 2007